Theranostic Treatment Response and Toxicity Risk Application Note
By assessing patient treatment efficacy and toxicity risk earlier in theranostic therapy, investigators will be able to differentiate those patients who are likely to have an optimal vs. sub-optimal response. This information can impact the overall clinical outcome and reduce the number of severe or life-threatening adverse events, resulting in more efficient drug discovery timelines.